{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:00:29Z","timestamp":1782792029054,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T00:00:00Z","timestamp":1367625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s11033-013-2554-y","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T12:03:27Z","timestamp":1367582607000},"page":"4613-4618","source":"Crossref","is-referenced-by-count":14,"title":["Genetic polymorphisms of vascular endothelial growth factor and risk for retinopathy of prematurity in South of Iran"],"prefix":"10.1007","volume":"40","author":[{"given":"Zahra Asadi","family":"Kalmeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Azarpira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Mosallaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Malekpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,4]]},"reference":[{"key":"2554_CR1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9394(42)92088-9","volume":"25","author":"TL Terry","year":"1942","unstructured":"Terry TL (1942) Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am J Ophthalmol 25:203\u2013204","journal-title":"Am J Ophthalmol"},{"issue":"437","key":"2554_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2002.tb00157.x","volume":"91","author":"LEH Smith","year":"2002","unstructured":"Smith LEH (2002) Pathogenesis of retinopathy of prematurity. Acta Paediatr Suppl 91(437):26\u201328","journal-title":"Acta Paediatr Suppl"},{"issue":"2","key":"2554_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tcm.2009.04.004","volume":"19","author":"Y Kubota","year":"2009","unstructured":"Kubota Y, Suda T (2009) Feedback mechanism between blood vessels and astrocytes in retinal vascular development. Trends Cardiovasc Med 19(2):38\u201343","journal-title":"Trends Cardiovasc Med"},{"issue":"10","key":"2554_CR4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/bjo.86.10.1122","volume":"86","author":"E Larsson","year":"2002","unstructured":"Larsson E, Carle-Petrelius B, Cernerud G, Ots L, Wallin A, Holmstr\u00f6m G (2002) Incidence of ROP in two consecutive population-based studies. Br J Ophthalmol 86(10):1122\u20131126","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"2554_CR5","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/bjo.2005.073650","volume":"89","author":"BA Darlow","year":"2005","unstructured":"Darlow BA, Hutchinson JL, Simpson JM, Henderson-Smart DJ, Donoghue DA, Evans NJ (2005) Variation in rates of severe retinopathy of prematurity among neonatal intensive care units in the Australian and New Zealand Neonatal Network. Br J Ophthalmol 89(12):1592\u20131596","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"2554_CR6","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/bjo.2007.117283","volume":"91","author":"G Holmstr\u00f6m","year":"2007","unstructured":"Holmstr\u00f6m G, van Wijngaarden P, Coster DJ, Williams KA (2007) Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies. Br J Ophthalmol 91(12):1704\u20131708","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"2554_CR7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1542\/peds.2004-1309","volume":"115","author":"BA Darlow","year":"2005","unstructured":"Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ (2005) Australian and New Zealand Neonatal Network. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics 115(4):990\u2013996","journal-title":"Pediatrics"},{"issue":"2","key":"2554_CR8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1034\/j.1600-0420.1998.760216.x","volume":"76","author":"G Holmstr\u00f6m","year":"1998","unstructured":"Holmstr\u00f6m G, Broberger U, Thomassen P (1998) Neonatal risk factors for retinopathy of prematurity\u2014a population-based study. Acta Ophthalmol Scand 76(2):204\u2013207","journal-title":"Acta Ophthalmol Scand"},{"issue":"6","key":"2554_CR9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaapos.2012.09.004","volume":"16","author":"L Kong","year":"2012","unstructured":"Kong L, Fry M, Al-Samarraie M, Gilbert C, Steinkuller PG (2012) An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS 16(6):501\u2013507","journal-title":"J AAPOS"},{"issue":"7","key":"2554_CR10","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1210\/jc.87.7.3413","volume":"87","author":"A Hellstr\u00f6m","year":"2002","unstructured":"Hellstr\u00f6m A, Carlsson B, Niklasson A, Segnestam K, Boguszewski M, de Lacerda L, Savage M, Svensson E, Smith L, Weinberger D (2002) Albertsson Wikland K, Laron Z. IGF-1 is critical for normal vascularization of the human retina. J Clin Endocrinol Metab 87(7):3413\u20133416","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2554_CR11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archophthalmol.2010.158","volume":"128","author":"SJ Budd","year":"2010","unstructured":"Budd SJ, Thompson H, Hartnett ME (2010) Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity. Arch Ophthalmol 128(8):1014\u20131021","journal-title":"Arch Ophthalmol"},{"key":"2554_CR12","first-page":"345","volume":"14","author":"P Geisen","year":"2008","unstructured":"Geisen P, Peterson LJ, Martiniuk D, Uppal A, Saito Y, Hartnett ME (2008) Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. Mol Vis 14:345\u2013357","journal-title":"Mol Vis"},{"issue":"1","key":"2554_CR13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","volume":"120","author":"JW Miller","year":"2013","unstructured":"Miller JW, Le Couter J, Strauss EC, Ferrara N (2013) Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 120(1):106\u2013114","journal-title":"Ophthalmology"},{"issue":"4","key":"2554_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12041-009-0068-0","volume":"88","author":"Y Qazi","year":"2009","unstructured":"Qazi Y, Maddula S, Ambati BK (2009) Mediators of ocular angiogenesis. J Genet 88(4):495\u2013515","journal-title":"J Genet"},{"issue":"2","key":"2554_CR15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","volume":"10","author":"J Chen","year":"2007","unstructured":"Chen J, Smith LE (2007) Retinopathy of prematurity. Angiogenesis 10(2):133\u2013140","journal-title":"Angiogenesis"},{"issue":"5","key":"2554_CR16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.exer.2004.07.006","volume":"79","author":"XQ Werdich","year":"2004","unstructured":"Werdich XQ, McCollum GW, Rajaratnam VS, Penn JS (2004) Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy. Exp Eye Res 79(5):623\u2013630","journal-title":"Exp Eye Res"},{"issue":"26","key":"2554_CR17","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","volume":"367","author":"ME Hartnett","year":"2012","unstructured":"Hartnett ME, Penn JS (2012) Mechanisms and management of retinopathy of prematurity. N Engl J Med 367(26):2515\u20132526","journal-title":"N Engl J Med"},{"issue":"10","key":"2554_CR18","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1167\/iovs.12-9727","volume":"53","author":"FB Vailati","year":"2012","unstructured":"Vailati FB, Crispim D, Sortica DA, Souza BM, Brondani LA, Canani LH (2012) The C allele of -634G\/C polymorphism in the VEGFA gene is associated with increased VEGFA gene expression in human retinal tissue. Invest Ophthalmol Vis Sci 53(10):6411\u20136415","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2554_CR19","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00417-008-0865-9","volume":"246","author":"P Kwinta","year":"2008","unstructured":"Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Pietrzyk JJ (2008) The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246(10):1467\u20131475","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"2554_CR20","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1167\/iovs.03-1303","volume":"45","author":"RW Cooke","year":"2004","unstructured":"Cooke RW, Drury JA, Mountford R, Clark D (2004) Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 45(6):1712\u20131715","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2554_CR21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1203\/01.PDR.0000153867.80238.E0","volume":"57","author":"A Vannay","year":"2005","unstructured":"Vannay A, Dunai G, B\u00e1ny\u00e1sz I, Szab\u00f3 M, V\u00e1mos R, Treszl A, Hajd\u00fa J, Tulassay T, V\u00e1s\u00e1rhelyi B (2005) Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res 57(3):396\u2013398","journal-title":"Pediatr Res"},{"issue":"5","key":"2554_CR22","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/diabetes.51.5.1635","volume":"51","author":"T Awata","year":"2002","unstructured":"Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S (2002) A common polymorphism in the 5\u2032-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51(5):1635\u20131639","journal-title":"Diabetes"},{"issue":"4","key":"2554_CR23","first-page":"812","volume":"63","author":"A Stevens","year":"2003","unstructured":"Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63(4):812\u2013816","journal-title":"Cancer Res"},{"issue":"10","key":"2554_CR24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00417-008-0865-9","volume":"246","author":"P Kwinta","year":"2008","unstructured":"Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Pietrzyk JJ (2008) The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246(10):1467\u20131475","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2554_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/02713683.2012.731550","volume":"38","author":"M Kaya","year":"2013","unstructured":"Kaya M, Cokakli M, Berk AT, Yaman A, Yesilirmak D, Kumral A, Atabey N (2013) Associations of VEGF\/VEGF-Receptor and HGF\/c-Met promoter polymorphisms with progression\/regression of retinopathy of prematurity. Curr Eye Res 38(1):137\u2013142","journal-title":"Curr Eye Res"},{"issue":"7","key":"2554_CR26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the classification of Retinopathy of Prematurity (2005) The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 123(7):991\u2013999","journal-title":"Arch Ophthalmol"},{"key":"2554_CR27","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1006\/cyto.2000.0692","volume":"12","author":"CJ Watson","year":"2000","unstructured":"Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12:1232\u20131235","journal-title":"Cytokine"},{"issue":"4","key":"2554_CR28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.11238","volume":"106","author":"P Krippl","year":"2003","unstructured":"Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H (2003) A common 936 C\/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106(4):468\u2013471","journal-title":"Int J Cancer"},{"issue":"3","key":"2554_CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0974-9233.97922","volume":"19","author":"M Afarid","year":"2012","unstructured":"Afarid M, Hosseini H, Abtahi B (2012) Screening for retinopathy of prematurity in South of Iran. Middle East Afr J Ophthalmol 19(3):277\u2013281","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"4","key":"2554_CR30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0002-9440(10)65004-3","volume":"156","author":"K Lashkari","year":"2000","unstructured":"Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N (2000) Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol 156(4):1337\u20131344","journal-title":"Am J Pathol"},{"issue":"2","key":"2554_CR31","first-page":"307.e2","volume":"153","author":"Y Ma","year":"2012","unstructured":"Ma Y, Zhang Y, Zhao T, Jiang YR (2012) Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab. Am J Ophthalmol 153(2):307.e2\u2013313.e2","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2554_CR32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/02713680802018427","volume":"33","author":"G Dunai","year":"2008","unstructured":"Dunai G, V\u00e1s\u00e1rhelyi B, Szab\u00f3 M, Hajd\u00fa J, M\u00e9sz\u00e1ros G, Tulassay T, Treszl A (2008) Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity. Curr Eye Res 33(5):501\u2013505","journal-title":"Curr Eye Res"},{"issue":"7","key":"2554_CR33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1440-1797.2009.01085.x","volume":"14","author":"HW Kim","year":"2009","unstructured":"Kim HW, Ko GJ, Kang YS, Lee MH, Song HK, Kim HK, Cha DR (2009) Role of the VEGF 936 C\/T polymorphism in diabetic microvascular complications in type 2 diabetic patients. Nephrology (Carlton) 14(7):681\u2013688","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"2554_CR34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ndt\/gfl641","volume":"22","author":"M Buraczynska","year":"2007","unstructured":"Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L (2007) Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol Dial Transplant 22(3):827\u2013832","journal-title":"Nephrol Dial Transplant"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2554-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-013-2554-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2554-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T10:39:45Z","timestamp":1563014385000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-013-2554-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,4]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2554"],"URL":"https:\/\/doi.org\/10.1007\/s11033-013-2554-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,4]]}}}